Hide Board Information

Show Board Information

Prothena Corp. plc PRTA

Board Mod: Add me as mod

Asst Mods:

Last Post: 01/09/2024 8:00:49 AM

Board Marks: 0

Posts Today: 0

Board Views Today: 8

Prothena Corp. plc (NASDAQ: PRTA) Stock Message Board

1. PRTA Company Profile

    

2. PRTA Time & Sales

    

3. PRTA Recent News

    

4. PRTA Filings

    

5. PRTA Financials

    

6. PRTA Buy Rating

Create New Post View All Posts Board Mark Banned

Post

Subject

Author

Posted On

7	PRTA 23.75 Prothena Corporation Plc Stock Charts	chartguy89	11/12/2014 8:48:54 AM
6	Right now PRTA is number 101 for the largest	danrocks	11/11/2014 1:08:03 PM
5	PRTA 23.48 Prothena Corporation Plc Stock Charts	chartguy89	11/11/2014 9:26:45 AM
4	PRTA Year to date has changed -11.46% percent.	Jake13	11/11/2014 8:26:04 AM
3	Latest Prothena Corporation Plc (PRTA) Headlines	Stock_Tracker	03/13/2014 12:48:41 PM
2	PRTA Stock Charts Last: +0.11 Saturday, March 1,	chartguy89	03/01/2014 9:27:01 PM
1	PRTA Stock Charts Last: +1.44 Friday, February	chartguy89	02/28/2014 3:35:49 AM

Newer

Recent Articles

• Stifel Financial Expands Wealth Management with New Advisors
• Zefiro Methane Corp. Innovates with New Patent for Eco-Friendly Solutions
• Helium Evolution's Exciting Financing Milestone with ENEOS
• Stellus Capital's Exciting Dividend Announcement for 2025
• Investors Can Join Class Action Against Ready Capital Now
• Hormel Foods Embraces New Leadership to Enhance Supply Chain
• Stellus Private Credit BDC Declares Regular Dividend of $0.36
• FatPipe, Inc. Prepares for Exciting NASDAQ Journey with IPO
• Regulatory T-Cells Market Growth Driven by New Therapies
• Nestpoint Group's Investment Boosts Univest's Banking Potential
• Bluejay Diagnostics Secures $3.7 Million through Warrant Exercise Agreement
• Equity Awards Boost Employee Engagement at Rupert Resources
• NeuroSense Therapeutics Reveals Significant Advances in ALS Solutions
• Mark Wiedman Takes the Helm as President of PNC Financial
• Dr. Siren Chudgar Joins IMA Medical Group as Chief Medical Officer
• Firm Capital Mortgage Investment Corporation's Debenture Redemption Plan
• PainReform's Annual Business Update: Key Developments Ahead
• AirBoss Secures New Contracts Worth Up to $15.6 Million
• Pearl River Holdings Faces Filing Delay and Management Order
• Michael Corcoran Steps in as Interim CFO of Helios Fairfax Partners
• Kinross Gold Corporation's Upcoming Virtual Shareholder Meeting
• Anika Therapeutics Grants Stock Options to New Employee
• Dundee Precious Metals' 2025 Production Insights and Growth Strategy
• Monthly Dividend Update from Firm Capital Mortgage Investment Corp
• Merit Medical Systems Prepares for Financial Results Release
• Samaritan's Purse Launches Critical Medical Response in Myanmar
• Join the Class Action Against Actinium Pharmaceuticals, Inc.
• NASA Awards Major Safety Contract to ARES Technical Services
• Avicanna Updates Investors on Audit and Management Trade Order
• Alaska Air Group's Upcoming Q1 Results Webcast Announcement
• LendingClub Announces First Quarter 2025 Earnings Call Details
• Brock Heger Leads RZR Factory Racing to Victory at San Felipe 250
• Applied Behavioral Services Plans Move to Innovative Facility
• Canoe EIT Income Fund Declares April 2025 Distribution
• Class Action Insights for SoundHound AI Investors
• Wendy's Plans to Release Financial Results for Q1 2025
• AAR CORP Welcomes Sharon Purnell as Senior Vice President
• Waystar Set to Reveal First Quarter 2025 Results Soon
• ASUR Reports March Passenger Traffic Growth Across Regions
• Curaleaf to Share Financial Insights on Upcoming Q1 Meeting
• Encompass Health's Upcoming Earnings Call Details Revealed
• Vistra Corp Set to Announce Q1 2025 Financial Results
• Transform Your Business with CONVO GPT's AI Employee "Sara"
• Marvell's $2.5 Billion Automotive Ethernet Deal with Infineon
• Clarion Security Strengthens Market Position with New Acquisition
• Carl Black Orlando Unveils Exciting Tire Promotion for Savings
• Frontline plc Annual Report Highlights and Insights
• Jewett-Cameron Prepares to Reveal Q2 2025 Financial Results
• Jeune Aesthetics Welcomes Marc Forth as New CEO
• Pacira BioSciences Resolves Patent Issues for EXPAREL